SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-19-005885
Filing Date
2019-03-28
Accepted
2019-03-28 16:15:25
Documents
11
Period of Report
2019-05-21
Effectiveness Date
2019-03-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A bp18004x1_def14a.htm DEF 14A 1659936
2 bp18004x1_piecharts1.jpg GRAPHIC 98291
3 bp18004x1_proxycard01.jpg GRAPHIC 1234573
4 bp18004x1_proxycard02.jpg GRAPHIC 1445917
5 coachtemplate_chair.gif GRAPHIC 135
6 coachtemplate_check.gif GRAPHIC 141
7 coachtemplate_ex.gif GRAPHIC 88
8 coachtemplate_member.gif GRAPHIC 127
9 logo_footerprothena.jpg GRAPHIC 6866
10 logo_prothena.jpg GRAPHIC 18202
11 sig_awhoman.jpg GRAPHIC 16941
  Complete submission text file 0001140361-19-005885.txt   5352727
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 T804 011-353-1-236-2500
Prothena Corp plc (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35676 | Film No.: 19712129
SIC: 2834 Pharmaceutical Preparations